openPR Logo
Press release

Naloxone Market Revenue, opportunities 2026 by key Vendors Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L

01-31-2019 06:20 AM CET | Science & Education

Press release from: Coherent Market Insights

Naloxone Market

Naloxone Market

Increasing launches and approval of novel naloxone products by various regulatory bodies is expected to be a major factor aiding in growth of the market over the forecast period. For instance, in January 2017, the U.S. Food and Drug Administration (FDA) approved Adapt Pharma Inc.’s NARCAN Nasal Spray 2 mg formulation for emergency treatment of known or suspected opioid overdose. In 2016, Mylan N.V. launched its naloxone hydrochloride injection USP, 0.4 mg/mL packaged in 1 mL single-dose vials. It is therapeutically equivalent to the naloxone hydrochloride injection 0.4 mg/mL, of Hospira Inc. In September 2017, Mundipharma International Limited received approval from European Medicines Agency (EMA) for its product (intranasal naloxone 1.8 mg) to use in emergency reversal of opioid overdose.

Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1804

Increasing cases of opioid overdose is expected to increase demand for naloxone products during emergency treatments which in turn will positively drive the global naloxone market growth. For instance, according to the data published by the U.S. Department of Health and Human Services (HHS) in 2016, around 11.5 million people misuse prescription drugs and around 948,000 people use heroin. According to the data published by National Institute on Drug Abuse, 2018, in the U.S., everyday over 115 people die due to opioid overdosing. According to same source, in the U.S. opioid overdose increased by 30% from July 2016 through September 2017 in 52 areas in 45 states.

Reimbursement scenario for drugs play a major role in adoption of high cost products in developed regions such as North America and Europe. Therefore, favorable reimbursements for naloxone products is expected to support the adoption of these products. Currently, most types of insurance cover and reimburse for naloxone administered directly in a medical setting.

Furthermore, some states in the U.S. have started covering take-home naloxone. Hence, adoption of take-home naloxone is expected to increase in the near future. For instance, in New York State from January 2014, the state’s Medicaid program began to cover the intramuscular formulation of take?home naloxone.

Furthermore, Europe naloxone market is expected to show significant growth in the near future, owing to increasing approvals of novel naloxone products in the region. For instance, in July 2017, Indivior Inc., a subsidiary of Indivior Plc., received marketing authorization (MA) from French Regulatory Agency ANSM for its new Nalscue naloxone hydrochloride nasal spray indicated for emergency treatment of characterized or suspected opioid overdose in France. In February 2017, Adapt Pharma Limited filed marketing application for its product Naloxone Hydrochloride (HCl) nasal spray in Europe. Hence, these products when launched in the European market it will drastically fuel market growth in the near future

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1804

According to the data published by Regulatory Affairs Professional Society, naloxone is still not approved by the U.S. FDA as an over-the-counter (OTC) drug. However, some organizations such as Walgreens pharmacies are providing naloxone products over-the-counter in over 5,800 of its 8,200 stores to increase the access of naloxone.

Key players operating in the naloxone market include Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Naloxone Market Revenue, opportunities 2026 by key Vendors Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L here

News-ID: 1548183 • Views: 338

More Releases from Coherent Market Insights

Durable Medical Equipment Market Investments Analysis towards 2027 - Stryker Cor …
Durable Medical Equipment Market report provides a thoroughly researched abstract of the key players with considerable shareholdings at a global level regarding demand, sales, and income by providing better products and services. Research Report outlines a forecast for the Durable Medical Equipment market between 2020 and 2027. In terms of value, the Durable Medical Equipment industry is expected to register a steady CAGR during the forecast period. The report offers a
flavor enhancer market Trends, Regional Analysis and Forecast 2027 | Internation …
Flavor Enhancer Market reports cover complete modest view with the market stake and company profiles of the important contestants working in the worldwide market. The Flavor Enhancer market offers a summary of product specification, production analysis, technology, product type, considering key features such as gross, gross margin, revenue, cost. Flavor Enhancer Market report provides key statistics on the Market status of the Flavor Enhancer manufacturers and is a valuable source of
Fibromyalgia Treatment Market To be lead by Eli Lilly and Company, Pfizer, Inc., …
Fibromyalgia Treatment Market report provides a thoroughly researched abstract of the key players with considerable shareholdings at a global level regarding demand, sales, and income by providing better products and services. Research Report outlines a forecast for the Fibromyalgia Treatment market between 2020 and 2027. In terms of value, the Fibromyalgia Treatment industry is expected to register a steady CAGR during the forecast period. The report offers a systematic presentation of
Bispyribac Sodium Market Analysis, Competition status, and Industry Demand 2027 …
Bispyribac Sodium Market reports cover complete modest view with the market stake and company profiles of the important contestants working in the worldwide market. The Bispyribac Sodium market offers a summary of product specification, production analysis, technology, product type, considering key features such as gross, gross margin, revenue, cost. Bispyribac Sodium Market report provides key statistics on the Market status of the Bispyribac Sodium manufacturers and is a valuable source of

All 5 Releases


More Releases for Naloxone

Naloxone Market Marketing Channel, Future Trends, Manufacturers Novartis AG, Ind …
Naloxone is a medication which is mainly used to reverse opioid overdose such as morphine and heroine. Naloxone is an opioid antagonist and the U.S. Food and Drug Administration (FDA) list it under prescription drugs, however some countries such as Italy and Australia have rescheduled it as an over-the-counter (OTC) medication. Naloxone products are available in various strengths. Currently, the available strengths of naloxone include 0.4 mg/ml, 1mg/ml, 0.4mg/0.4ml, 4mg/0.1ml,
Global Naloxone Market 2018 - ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, k …
The Global Naloxone Market 2018 - overview combining the data integration and analysis capabilities with the relevant findings, the report has predicted strong future growth of the market. The research analyst combining secondary research which involves reference to various statistical databases, relevant patent and regulatory databases and a number of internal a nd external proprietary databases. Cell Line Development Equipment report has focused on each region market size in
Naloxone Market Outlook To 2025: Top Key Players Are ADAPT Pharma, Amphastar Pha …
The “Naloxone Market” research report covers the data which is helpful for top manufacturers, product scope, market overview, market opportunities, market risk, market driving force, technological advancement, distributors, traders, dealers, research findings. These data representations provide predictive data regarding the future estimations for convincing market growth. The objectives of this study are to define, segment, and project the size of the Naloxone market based on company, product type, application and
Global Naloxone Market Specifications, Emerging Growth Factors & Application 202 …
Qyresearchreports include new market research report "Global Naloxone Sales Market Report 2018" to its huge collection of research reports. QYResearchReports.com has added a new report covering the global Naloxone market to its vast database. The research report studies the global Naloxone market to analyze the factors impacting it. The report has been divided into several chapters that discuss the global Naloxone market in absolute detail. The report begins with the discussion
Naloxone Market trend, outlook 2025
Naloxone is an opioid antagonist used to counter the effects of opioid overdose, such as morphine and heroine. Naloxone is indicated for use in opioid overdose to counteract life-threatening depression of the central nervous system and respiratory system, allowing an overdose victim to breathe normally. Naloxone is non-scheduled prescription medication, which in most cases, is administrated by emergency response personnel or minimally trained personnel, and is thus ideal for treating
Naloxone Sales Market 2017 by Current & Upcoming Trends
Qyresearchreports include new market research report Global Naloxone Sales Market Report 2017 to its huge collection of research reports. This business and commerce study on the global Naloxone market has been freshly compiled by a group of professional market research analysts and aspires to serve a reliable business tool for the stockholders of this market. The report begins with an overview of the global Naloxone market, evaluating market performance in terms